WSU 2017 Translational Medicine Symposium - October 27

Friday, October 27, 2017

When: October 27, 2017, from 9 a.m. to 5:30 p.m.
Where: Providence Auditorium, 20 W 9th Ave, Spokane, WA 99202

RSVP for full or partial attendance here


WSU Health Sciences Spokane’s Translational Medicine Symposium will connect scientists, entrepreneurs, physicians, patients, and families to work toward novel solutions for clinical problems.

The focus for this inaugural edition of the event will be on:

  • Neurodegenerative diseases, such as ALS and Alzheimer’s disease
  • Oncology, with a focus on recurrent glioblastoma brain tumors

Through keynote and guest lectures, the program will showcase research and expertise in these areas within WSU and in the community. A novel cornerstone of the day will be the reverse-pitch session that will allow patients, families, and clinicians to share specific issues and challenges faced by those affected. An expert panel will help identify and discuss solutions to bridge the gap from idea to marketplace.

Here’s what you can expect at the Translational Medicine Symposium:

  • Coffee and networking
  • Welcome and introductions
  • Research presentation featuring Northwest Neurological, a Spokane-based private practice neurology group.
  • Guest lecture and moderated Q&A featuring Chris Rivera, president and CEO, and Ken Ferguson, chief scientific officer, Nativis. Nativis develops non-invasive, non-toxic disease treatments, with an initial focus on glioblastoma.
  • Lunch and networking
  • Keynote address and moderated Q&A featuring Rhonda Rhyne, author of “Keys to the Corner Office: Success Strategies for Women by Women” and president and CEO of medical technology company Prevencio.
  • Reverse-pitch session with expert panel. Patients, families, and clinicians will share particular pain-points and day-to-day challenges, with the goal of making specific asks for tools, devices, technologies, clothing/bedding modifications, and so on.
  • Guest lecture and moderated Q&A featuring Joseph W. Harding, PhD, cofounder and chief scientific officer, M3 Biotechnology. M3 Biotechnology develops therapeutics for neurodegenerative diseases based on disease-modifying regenerative small molecules.
  • Poster session and networking reception

Pre-Symposium Event: 2017 ALS Forum, October 26

Symposium attendees interested in learning from patients living with ALS are encouraged to attend the pre-symposium 11th Annual ALS Forum, Thursday, October 26, 2017, 5:30 p.m. to 7:00 p.m., in the Spokane Academic Center Auditorium (SAC 20) on the WSU Health Sciences Spokane campus.

This year’s topic is “Bridging the Gaps in Quality Care.” It will feature a panel of ALS patients and their caregivers who will address the realities of life with ALS and discuss how healthcare delivery can be improved from a patient-centered viewpoint.

The annual event is free and open to the public and is sponsored by the WSU Elson S. Floyd College of Medicine – Department of Speech and Hearing Sciences and the EWU College of Health Sciences – Department of Physical Therapy.

Poster Presentations

The WSU Health Sciences Spokane Translational Medicine Symposium research poster session is an excellent opportunity to present your latest research results, projects, and innovations to a professional audience that includes your academic peers. Posters from all disciplines and research areas are welcome. Commercial interests: please contact to inquire about poster or table/booth options.

Submit your poster information


Guidelines and Information

  • Posters may be displayed beginning at 9 a.m.
  • Each poster will be allowed a poster board space of 36″ x 48”.
  • Posters should be readable from a distance of at least five feet.
  • Posters may be fastened to the boards with thumbtacks provided. The boards will be assigned numbers corresponding to the abstract in the conference program. Please locate your abstract number, and fasten your poster to the board assigned that number.
  • During the poster session and networking reception, you will be required to stand by your poster.
  • All posters must be removed by 6 p.m. Any posters remaining on display after that time will be discarded.

Submission Requirements (due by Wednesday, Oct. 18, 2017):

  • Poster title
  • Poster author information
  • Short poster abstract (250 words maximum)
  • Topic area
  • One to five keywords

If you have any questions regarding the symposium or your presentation, please email